Abstract | OBJECTIVES: METHODS: RESULTS: TTF-1 and napsin A identified PLA in PLA-EPM/ EPA with a sensitivity of 89.4% and 93.3% and a specificity of 93.9% and 94.7%, respectively. PLA was confirmedin 47.4% of PLA-EPM and 40.2% of PLA-EPA. Overall, 38.5% of patients with PLA had EPM. The common organs for PLA-EPA were breast (35.8%), colon (13.2%), and others, whereas the common organs resulting in pulmonary metastasis were the colon (32.8%), breast (28.1%), and others. A patient with a smoking history and without EPM had a higher chance of having PLA. Multiple nodules are not a reliable indication of metastatic adenocarcinoma. CONCLUSIONS: Our results firmly support the role of TTF-1 and napsin A in identifying PLA-EPM/EPA. We reason that all new lung nodules in patients with a history of EPM should be screened using these techniques due to the high frequency of PLA-EPM, which will affect treatment and prognosis of patients with EPM/EPA.
|
Authors | Bing Zhu, Shavari Dalal, David W Kamp, Xiaoqi Lin |
Journal | American journal of clinical pathology
(Am J Clin Pathol)
Vol. 141
Issue 3
Pg. 429-36
(Mar 2014)
ISSN: 1943-7722 [Electronic] England |
PMID | 24515772
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- NKX2-1 protein, human
- Nuclear Proteins
- Thyroid Nuclear Factor 1
- Transcription Factors
- Aspartic Acid Endopeptidases
- NAPSA protein, human
|
Topics |
- Adenocarcinoma
(diagnosis, pathology, secondary)
- Adult
- Aged
- Aged, 80 and over
- Aspartic Acid Endopeptidases
(metabolism)
- Biomarkers, Tumor
(metabolism)
- Diagnosis, Differential
- Female
- Humans
- Lung Neoplasms
(diagnosis, pathology, secondary)
- Male
- Middle Aged
- Nuclear Proteins
(metabolism)
- Sensitivity and Specificity
- Thyroid Nuclear Factor 1
- Transcription Factors
(metabolism)
|